Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Japan Faces Suits By Possible Million-Plus Hepatitis B Carriers

This article was originally published in PharmAsia News

Executive Summary

Although Japanese authorities settled a group of hepatitis C cases out of court, it still could be sued by more than a million hepatitis B patients. A suit is expected to be filed in Sapporo District Court seeking compensation for several hepatitis B patients who assert they contracted the virus through mandatory vaccinations. The several plaintiffs in that suit seek between $152,000 and $606,000 in compensation in addition to help in treating their disease. The Health, Labor and Welfare Ministry estimates more than 1 million hepatitis B carriers in Japan. (Click here for more

Latest Headlines
See All
UsernamePublicRestriction

Register

SC068023

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel